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and Ning Li*Abstract
Sepsis-associated encephalopathy (SAE) is a diffuse brain dysfunction that occurs secondary to infection in the body
without overt central nervous system (CNS) infection. SAE is frequently encountered in critically ill patients in
intensive care units and can be detected in up to 50–70% of septic patients. Previous studies have demonstrated
that inflammatory cytokine release and oxidative stress injury are major pathophysiological mechanisms of SAE in
critically ill patients. However, there are no effective strategies for the treatment of SAE. Insulin has important
immunomodulatory effects and protective effects against oxidative stress injury in the peripheral organs of septic
patients. However, very few studies of the possible effects of insulin in cerebral tissues of septic patients have been
reported. Therefore, in this study, we aimed to explore whether insulin therapy can inhibit cytokine production
(IL-1, IL-6, and TNF-a) and oxidative stress injury of the brain tissue in septic rats. We observed that the protein
concentrations of IL-1, IL-6, and TNF-а, in addition to MDA and H2O2 were notably increased, inversely SOD, and
GSH were sigificantly decreased in cortex, hippocampus, and hypothalamus of septic rats. Furthermore, the levels of
S100 and NSE significantly increased. After 6 hours of insulin therapy, we found that the cytokine concentrations
notably decreased and oxidative stress injuries in the cortex, hypothalamus, and hippocampus were alleviated in
septic rats. In addition, the S100 and NSE levels significantly decreased. We concluded that insulin can inhibit the
production of inflammatory cytokines and the oxidative stress response, thereby improving brain tissue damage.
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Sepsis-associated encephalopathy (SAE) is a diffuse brain
dysfunction that occurs secondary to infection in the
body in the absence of central nervous system (CNS) in-
fection. SAE is often observed in critically ill patients
and can be detected in up to 50–70% of septic patients
[1,2]. However, there are no effective treatment strategies
for SAE. The severity of SAE can range from mild deli-
rium to deep coma. Patients with acutely altered mental
status associated with encephalopathy have higher morta-
lity rates (49%) than patients with pre-existing mental sta-
tus changes (41%) or a normal mental status (26%) [1]
(Figures 1, 2, 3, 4, 5, 6, 7, 8 and 9).* Correspondence: NingLinju@hotmail.com
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reproduction in any medium, provided the orPrevious studies have established that inflammatory
cytokine release and oxidative stress injury are major
pathophysiological mechanisms of sepsis, resulting in in-
jury to system tissues and organs [3,4]. Further studies
have shown that the mechanisms underlying sepsis are re-
lated to cytokine generation and oxidative stress injury
[3,5]. These effects can have several deleterious conse-
quences, including nerve cell apoptosis and necrosis [6-8],
neuronal bioenergetic failure and cerebral oxidative me-
tabolism injury [9], axonal injury and brain tissue edema
[10,11], neurotransmitter transporter inhibition [12], and
destruction of the blood–brain barrier [7]. A number of
studies have confirmed that anti-inflammatory cytokines
and reduction in oxidative stress have significant protect-
ive effects against brain injury [8,13-17]. Therefore, the in-
hibition of inflammation and oxidative stress can prevent
brain tissue injury and ameliorate SAE.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in IL-1β in different brain regions (cortex,
hypothalamus and hippocampus). Value are expressed as
mean +/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, ##p<0.01.
Figure 3 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in TNF-α in different brain regions (cortex,
hypothalamus and hippocampus). Value are expressed as
mean +/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #P<0.05, ##p<0.01.
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sulin therapy in critically ill patients. In particular, the
results of 2 milestone investigations conducted between
2001 and 2009 showed contradictory mortality benefits
[18,19]. There are conflicting opinions on whether insu-
lin therapy itself, in addition to the modification of glu-
cose levels (regulated by insulin), is suitable for criticalFigure 2 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in IL-1β in different brain regions (cortex,
hypothalamus and hippocampus). Value are expressed as
mean +/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #p<0.05, ##p<0.01.care patients. Insulin therapy provides better controllabil-
ity and maneuverability in animal experiments and there-
fore has obvious benefits in animal models. In addition to
the regulation of glucose levels, insulin therapy has im-
portant immunomodulatory effects in septic patients. Pre-
vious studies conducted by our group and others have
demonstrated that insulin therapy can directly inhibit theFigure 4 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in MDA in different brain regions (cortex,
hypothalamus and hippocampus). Value are expressed as
mean +/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #P<0.05, ##p<0.01.
Figure 5 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in SOD in different brain regions (cortex,
hypothalamus and hippocampus). Value are expressed as
mean +/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #p<0.05.
Figure 7 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in H2O2 in different brain regions (cortex,
hypothalamus and hippocampus). Value are expressed as mean
+/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #p<0.05.
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septic conditions [4,20]. Furthermore, it can also inhibit
the transcription factor NF-κB with subsequent down-
regulation of proinflammatory cytokines [21]. In addition,
insulin can suppress oxidative stress by amelioratingFigure 6 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in GSH in different brain regions (cortex,
hypothalamus and hippocampus). Value are expressed as mean
+/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #p<0.05.mitochondrial function or inhibiting the release of cy-
tokines in septic patients and animals [21,22].
At present, studies of insulin therapy for critical care
subjects focus on peripheral tissues, and very few stu-
dies assessing whether insulin can influence cerebral
tissues of septic patients have been reported. There-
fore, in this study, we aimed to explore whether insulin
therapy can inhibit the production of cytokines (IL-1,
IL-6, and TNF-a) and oxidative stress injury of the
brain tissue in septic rats. Our findings may provide a
theoretical basis for the clinical treatment of SAE.Figure 8 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in S100 in serum. Value are expressed as mean
+/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #p<0.05.
Figure 9 Effect of insulin (4.8 mu/kg/min) on LPS (10 mg/kg)
induced changes in NSE in serum. Value are expressed as mean
+/- SD of each group (n=6). Compared with control group,
**p<0.01, compared with sepsis group, #p<0.05.
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Animals
In this study, we used 54 adult male Sprague–Dawley rats,
weighing 280 ± 20 g, from the animal center of Jinling
Hospital. The Institutional Animal Care Committee ap-
proved the study protocol. The Association accredits the
animal care facility for Assessment and Accreditation of
Laboratory Animal Care. Rats were housed in mesh cages
in a 25°C room, illuminated in 12-h light: 12-h dark cycles.
The animals were allowed to acclimatize to their environ-
ment for 7 d before the start of the study. They were pro-
vided with standard rodent chow and water ad libitum.
The rats were fasted for 12 h immediately before the
experiment.
Animal preparation
Rats were anesthetized intraperitoneally with phenobar-
bital sodium (60 mg/kg). Catheters (PE-50, PE-10; Becton-
Dickinson, Sparks, MD) were implanted into the right
femoral vein for the infusion of insulin and dextrose solu-
tions via a micropump (provided by the Research Center
for Analytical Instrument, Zhejiang University). The cath-
eters were filled with saline containing heparin sodium.
About 1 mm of the tail tip was cut for monitoring blood
glucose levels. The scab of the incision was abscised with
75% alcohol every time. The area around the incision was
gently squeezed and the first drop of blood was discarded;
the next drop was used for monitoring using an Elite glu-
cometer (Bayer, Elkhart, IN).
Group distribution and insulin infusion strategy
After the animals were prepared for the experiments, they
were divided randomly into 3 groups as follows: control
group (n = 12), LPS group (n = 12), and insulin treatmentgroup (n = 12). The sepsis model was mimicked by intra-
peritoneal injection of 10 mg/kg LPS (Escherichia coli
serotype 055:B5; Sigma, St. Louis, MO). The rats in the in-
sulin treatment group received a continuous infusion of
insulin (Humulin R, Eli Lilly & Co., Indianapolis, IN) at
a constant rate of 4.8 mU · min−1 · kg−1 for 6 h after LPS
stimulation. Blood glucose was maintained at 140–
180 mg/dL by varying the infusion rate of a 50% dextrose
solution. The LPS group was injected intraperitoneally
with 10 mg/kg LPS only. The control group received an
intraperitoneal injection of an equal volume of sterile sa-
line only. The rats remained anesthetized for the duration
of the experiment by the continuous infusion of pheno-
barbital sodium.
At the end of the infusion, the rats were killed with an
overdose of phenobarbital sodium. The frontal cortex,
hippocampus, and hypothalamus were dissected and stored
at −80°C until analysis.Determination of protein concentrations of inflammatory
cytokines in cerebral tissues
To determine the protein concentrations of TNF-a,
IL-1β, and IL-6 in cerebral tissues (cortex, hypothal-
amus, and hippocampus), the tissues were diluted
(40% w/v) with 0.01 mol/L phosphate-buffered saline,
pH 7.4, containing a protease inhibitor cocktail (Roche,
Indianapolis, IN), and homogenized. The homogenates
were then centrifuged at 7,500 × g for 20 min at 4°C.
The levels of TNF-a, IL-1β, and IL-6 in the supernatant
were determined by enzyme-linked immunosorbent
assay performed using commercial kits (R&D Systems,
Minneapolis, MN) in accordance with the manufac-
turer’s instructions. The results are expressed as pg/mg
of brain tissue.Measurements of antioxidants and oxidant indices in
brain tissues
The tissue homogenates were utilized for the determin-
ation of antioxidants (SOD and GSH) and oxidant indices
(MDA) using commercial analysis kits (Nanjing Jiancheng
Bioengineering Institute, China). SOD and GSH activities
of the brain tissues (cortex, hypothalamus, and hippo-
campus; n = 6/region/group) are expressed in terms of
U/mg protein, and MDA concentrations are expressed
in nmol/mg (n = 6/group).Measurements of H2O2 in brain tissues
The tissue homogenates were utilized for the determin-
ation of H2O2 using commercial analysis kits (Nanjing
Jiancheng Bioengineering Institute, China). The concertra-
tions of H2O2 in brain tissue (n = 6/regions/group) were
expressed in terms of mmol/L.
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Blood samples were collected from the femoral vein at
6 h after insulin infusion for the measurement of S100
and neuron-specific enolase (NSE) levels. The blood
was allowed to clot for 20–30 min at room temperature
and then centrifuged and frozen at temperatures lower
than −70°C. Serum S100 and NSE levels were quantified
with an enzyme-linked immunosorbent assay (R&D,
USA) according to the manufacturer’s instructions.
Statistical analysis
Data are expressed as mean ± standard deviation (SD).
Statistical analysis was performed using ANOVA. All
data were analyzed using the SPSS software (Statistical
Package for the Social Sciences, version 20.0, for Windows,
SPSS, Chicago, IL). A p value < 0.05 was considered
significant.
Results
Variation in the protein concentrations of the cytokines
IL-1β, IL-6, and TNF-a in cerebral tissues
The protein concentrations of the cytokines IL-1β, IL-6,
and TNF-a in the cortex, hypothalamus, and hippocam-
pus significantly increased after intraperitoneal injection
of 10 mg/kg LPS (vs. control group, p < 0.01). When in-
sulin was injected at 4.8 mU · kg−1 · min−1 for 6 h, the
IL-6 and TNF-a levels decreased significantly in the cor-
tex, hypothalamus, and hippocampus (vs. sepsis group,
p < 0.05). Although the IL-1 level decreased only mildly
in the hypothalamus (122.11 ± 61.03 vs. 198 ± 70.49 in
the sepsis group, p = 0.21), it significantly decreased in
the cortex and hippocampus (vs. sepsis group, p < 0.05).
Variation in antioxidant and oxidant indices in
cerebral tissues
After injection of 10 mg/kg LPS, the MDA concentrations
in all brain regions (cortex, hypothalamus, and hippocam-
pus) notably increased (vs. control group, p < 0.01), but the
GSH and SOD activities in all brain regions significantly
decreased (vs. control group, p < 0.01). When insulin
was injected at 4.8 mU · kg−1 · min−1 for 6 h, IL-6 and
MDA levels decreased significantly in all brain regions
(vs. sepsis group, p < 0.05). SOD and GSH activities
were upregulated to different degrees in all brain re-
gions; SOD upregulation was most obvious in the cortex
and hypothalamus (vs. sepsis group, p < 0.05), whereas
GSH upregulation was most significant in the cerebral
cortex (vs. sepsis group, p < 0.05).
Variation in ROS system indices H2O2 in cerebral tissues
The H2O2 concentrations in all brain regions were not-
ably increased (vs. control group, p < 0.01), after injec-
tion of 10 mg/kg LPS. When insulin was injected by
4.8 mU/(kg∙min) for 6 hours, we found that H2O2 weredecreased sigificantly in cortex (vs. sepsis group, p < 0.05).
and the H2O2 were also decreased moderatly in hypotha-
lamus and hippocampu, although both no significant dif-
ference (vs. sepsis group, p > 0.05).
Variation in the serum protein levels of S100B and NSE
The concentrations of S100 and NSE in the serum not-
ably increased (vs. control group, p < 0.01) after injection
of 10 mg/kg LPS. However, when insulin was injected at
4.8 mU · kg−1 · min−1 for 6 h, the serum S100 and NSE
levels significantly decreased (vs. sepsis group, p < 0.05).
Discussion
During sepsis, the brain may be one of the first organs
affected [23,24]. SAE, a diffuse brain dysfunction, can be
detected in up to 50–70% of septic patients, and patients
with acute SAE have a high mortality rate (49%) [1,2].
Several lines of evidence indicate that an inflammatory
cascade and oxidative stress injury are the main mecha-
nisms of SAE. However, at present, the establishment of
therapeutic strategies for the treatment of SAE in clinical
practice is problematic.
Under septic conditions, the expression of cytokines
(e.g., IL-1, IL-6, TNF-а, and IL-10) is significantly upreg-
ulated in cerebral tissues. In agreement with this, our re-
sults show that the protein concentrations of the
cytokines IL-1, IL-6, and TNF-а notably increased in the
cortex, hippocampus, and hypothalamus of septic rats.
Numerous studies suggest that cytokines cause brain
toxicity. The reported injurious effects of cytokines in-
clude nerve cell apoptosis and necrosis [6-8], neuronal
bioenergetic failure and cerebral oxidative metabolism
injury [9], axonal injury and brain tissue edema [10,11],
neurotransmitter transporter inhibition [12], and de-
struction of the blood–brain barrier [7].
An imbalance between oxidants and antioxidants in
favor of the oxidants, potentially leading to damage, is
termed “oxidative stress”. Oxidants are formed as a nor-
mal product of aerobic metabolism, but they can also be
produced at elevated rates under pathophysiological
conditions [25]. The antioxidant systems in the body in-
clude SOD, glutathione peroxidase (GSH-Px), catalase,
and GSH [26,27]. MDA is the main oxidation product
of peroxidized polyunsaturated fatty acids, and an in-
creased MDA level is an important indication of lipid
peroxidation [26,27]. The brain is particularly susceptible to
oxidative stress because of its high metabolic rate, relatively
low capacity for cellular regeneration [28], and low antioxi-
dant capacity due to a lack of reduced GSH [29-31]. During
sepsis, oxidative stress injury is the main pathophysiological
mechanism of SAE. Our experimental results showed that
the levels of the antioxidants SOD and GHS notably
decreased in septic rats in every region of the brain
(hippocampus, hypothalamus, and cortex), whereas the
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to previous observations that an imbalance exists be-
tween oxidants and antioxidants during sepsis.
Reactive oxygen species (ROS) including superoxide
O−2 , hydrogen peroxide (H2O2), and hydroxyl radicals are
generated in both normal and pathological, biological
processes. ROS system can significantly were activated
and participated in the pathophysiology process of sepsis
[32]. The study found similar, in sepsis, H2O2 was in-
creased significantly. The present study found that H2O2
significantly reduced the GPx, SOD, and CAT activities,
while MDA level exposed to H2O2 was elevated,indicat-
ing disruptions of the endogenous antioxidant enzymes
[33]. Agents that inhibit the production of reactive oxy-
gen species or increase the antioxidant defense may pre-
vent apoptosis and protect cells from oxygen radicals
damage [33]. Insulin can prevent mitochondrial gener-
ation of H2O2 in normal rat neuronal cultures [34]. In our
results showed H2O2 were decreased in cortex, hypothal-
amus and hippocampus in different degree when insulin
was injected by 4.8 mU · kg−1 · min−1 for 6 hours.
Above-mentioned results show that insulin can inhibit
inflammatory cytokines and the oxidative stress response.
The interaction between cytokines and oxidative stress
has also been recently investigated. Cytokines have been
reported to increase the neutrophil oxidative respiratory
burst [35]; however, oxidative stress can be an initiator of
cytokine release and cell damage [36]. Therefore, with re-
spect to SAE, it might be useful to inhibit the inflamma-
tory response and correct the imbalance between oxidants
and antioxidants in brain tissues. In addition to the
regulation of blood glucose levels, insulin plays import-
ant roles in immune regulation and the inhibition of
oxidative stress injury. Our previous studies and a num-
ber of other reports have demonstrated that insulin can
significantly reduce the release of inflammatory cyto-
kines and improve the prognosis of critically ill patients
[20]. To date, studies of insulin therapy for critical care
subjects have focused on peripheral tissues, and the ef-
fects of insulin in the cerebral tissues of septic patients
have not been thoroughly investigated. Therefore, in
our experiment, we infused insulin intravenously at
4.8 mU · kg−1 · min−1 and maintained the blood glucose
level at 140–180 mmol/dL by intravenous infusion of a
50% dextrose solution. After 6 h of insulin therapy, we
found that cytokine concentrations notably decreased
and oxidative stress injury in the cortex, hypothalamus,
and hippocampus was alleviated in septic rats.
Serum S100B and NSE are specific biomarkers of cere-
bral injury [37,38]. S100B is most abundant in glial cells of
the CNS, mainly in astrocytes, while NSE is present almost
exclusively in the cytoplasm of neurons (γ–γ isoenzyme)
and neuroendocrine cells (α–γ isoenzyme). Therefore, in
our next study, we will further examine the serum contentof S100 and NSE. In the present study, we found that the
serum levels of S100 and NSE were notably increased after
injection of 10 mg/kg LPS. However, when insulin was
injected at 4.8 mU · kg−1 · min−1 for 6 h, we found that the
serum levels of S100 and NSE significantly decreased.
Therefore, the results of this study indicate that insulin can
inhibit cerebral injury.
In conclusion, our results show that insulin can inhibit
inflammatory cytokines and the oxidative stress response
and consequently improve brain tissue damage. The
findings of this study may provide a basis for the develop-
ment of treatment strategies for SAE in clinical practice.
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